TBXAS1 and ghosal hematodiaphyseal dysplasia: Considering the immunological aspects of GHDD, involving the TBXAS1 gene dysregulation, patients were treated with prednisone of varying dosages, either in short courses titrated to the patient's response or in maintenance doses indefinitely for refractory cases [2,4,11].